Enteroviral Meningitis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.1, 2001-01, pp. : 3-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cystic Fibrosis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies

By Krauth C.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1001-1024

Adis International

Access to resources Recommend Favorite

Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies

By Wong John B.

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 661-672

Adis International

Access to resources Recommend Favorite

Influenza: Cost of Illness and Considerations in the Economic Evaluation of New and Emerging Therapies

By Cram P.

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 223-230

Adis International

Access to resources Recommend Favorite

Acute Pyelonephritis Among Adults: Cost of Illness and Considerations for the Economic Evaluation of Therapy

By Brown Patricia

PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. : 1123-1142

Adis International

Access to resources Recommend Favorite

Antineoplastics/rituximab: Enteroviral aseptic meningitis: case report

Reactions Weekly, Vol. 1, Iss. 1419, 2012-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite